Sol-Gel Technologies Ltd. (SLGL)

0,8504 +0,0004 (+0,05%) Börsenschluss: 04:00PM EDT

Sol-Gel Technologies Ltd.

7 Golda Meir Street
Weizmann Science Park
Ness Ziona 7403650
Israel
972 8 931 3433
https://www.sol-gel.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 36

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Alon Seri-Levy	Co-Founder, CEO & Director	411k	N/A	1961
Mr. Gilad Mamlok	Chief Financial Officer	367k	N/A	1968
Dr. Itzik Yosef	Chief Operating Officer	236k	N/A	1976
Mr. Moshe Arkin	Executive Chairman of the Board	N/A	N/A	1953
Prof. David Avnir	Co-Founder	N/A	N/A	N/A
Ms. Tamar Fishman Jutkowitz	VP & General Counsel	N/A	N/A	1976
Dr. Karine Neimann	VP of Projects & Planning and Chief Chemist	N/A	N/A	1971

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Corporate Governance

Sol-Gel Technologies Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.